
Daniel Shouval, MD, provides an update on the latest management strategies for patients with chronic hepatitis B.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the efficacy of peginterferon alfa or nucleos(t)ides in treatment-naive, HBV-infected patients
- Discuss the safety and efficacy of changing treatment of HBV patients with suboptimal response to their initial nucleos(t)ide regimens
- Recount strategies and outcomes for transplantation and hepatocellular carcinoma in the setting of HBV infection